Growth Metrics

Quest Diagnostics (DGX) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $251.0 million.

  • Quest Diagnostics' Income from Continuing Operations rose 865.8% to $251.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $986.0 million, marking a year-over-year increase of 1359.45%. This contributed to the annual value of $902.0 million for FY2024, which is 226.76% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Income from Continuing Operations is $251.0 million, which was up 865.8% from $287.0 million recorded in Q2 2025.
  • Quest Diagnostics' Income from Continuing Operations' 5-year high stood at $640.0 million during Q2 2021, with a 5-year trough of $113.0 million in Q4 2022.
  • Moreover, its 5-year median value for Income from Continuing Operations was $242.0 million (2023), whereas its average is $290.1 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first surged by 41413.04% in 2021, then plummeted by 7087.63% in 2022.
  • Over the past 5 years, Quest Diagnostics' Income from Continuing Operations (Quarter) stood at $388.0 million in 2021, then crashed by 70.88% to $113.0 million in 2022, then soared by 74.34% to $197.0 million in 2023, then increased by 17.26% to $231.0 million in 2024, then increased by 8.66% to $251.0 million in 2025.
  • Its Income from Continuing Operations stands at $251.0 million for Q3 2025, versus $287.0 million for Q2 2025 and $217.0 million for Q1 2025.